- Atlas Air Worldwide Holdings: Susquehanna Financial downgrades to neutral from positive. PT up 2.8% to $102.50.
- Ball: Atlantic Equities LLP cut the recommendation to neutral from overweight. PT set to $58.
- BeiGene: ICBC Research reinstated coverage with a recommendation of buy. PT up 36% to $260.10.
- Bio-Techne: Stifel cut the target cut the target to $500 from $560. Maintains buy rating.
- Celanese: Piper Sandler cut the target to $120 from $145. Maintains underweight rating.
- ConvaTec: Bank of America downgrades to neutral from buy.
- Dunelm Group: Stifel initiated coverage with a recommendation of sell. PT down 18% to 700 pence.
- Eli Lilly: Cantor Fitzgerald maintains overweight rating. PT up 18% to $360.
- Epam Systems: Cowen raised the target to $440 from $400. Maintains outperform rating.
- Hikma Pharmaceuticals: Barclays downgrades to equal-weight from overweight. PT up 6% to 1.750 pence.
- Kellogg: Piper Sandler raised the recommendation to neutral from underweight. PT set to $74.
- KLA: Cowen cut the target to $55 from $68. Maintains market perform rating.
- Paramount Global: J.P. Morgan cut the recommendation to underweight from neutral. PT set to $25.
- Next: Goldman Sachs reduces to neutral from buy. PT up 13% to 7.600 pence.
- Unite Group: Stifel cut the recommendation to hold from buy. PT set to 1.170 pence.
- Yeti Holdings: Piper Sandler maintains overweight rating. PT down to $76.